Kairos Pharma CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference
Kairos Pharma's CEO will present a corporate overview at a major investment conference, highlighting the company's progress in developing ENV-105 to combat cancer drug resistance.
Rogue AI Incidents Spark Debate on Government Oversight and Industry Impact
Recent rogue AI incidents have led to multiple narratives and increased calls for government regulation, potentially affecting major tech companies like Microsoft.
US and EU Diverge on AI Regulation at G20 Meeting
At the G20 meeting, the US advocated for lighter AI regulation while the EU pushed for stronger rules, highlighting a transatlantic split with implications for global tech companies.
Australia Weighs Mandatory Opt-In for Social Media Algorithms
Australia considers requiring social media platforms to let users opt into recommendation algorithms, a move that could reshape digital engagement and platform accountability globally.
Expert Warns of Hidden Crisis in UTI Diagnosis Methods
A new expert commentary highlights flaws in current UTI diagnostic practices, underscoring the need for advanced testing technologies and the potential role of companies like Co-Diagnostics in develop...
Rising Treasury Yields Put Recent Bitcoin Rally Under Pressure
Bitcoin faces renewed selling pressure as rising Treasury yields challenge its recent rally, with upcoming economic data likely to influence crypto markets and affect companies like Marathon Digital H...
Fairchild Gold Engages TerraEye for Property-Wide Exploration at Golden Arrow Project
Fairchild Gold Corp. has engaged TerraEye to conduct a satellite-based spectral mapping and structural interpretation program at its Golden Arrow Gold-Silver Project in Nevada, aiming to identify new ...
EU Wind Sector Poised for Record Year in 2026 as Installations Surge
The European Union is on track to install a record 24 GW of wind capacity in 2026, driven by a 30% year-on-year increase in first-half installations, bringing the industry closer to its 30 GW annual t...
EV Sales Plummet in US, Raising Questions About Market Viability
Electric vehicle sales in the US have dropped sharply after the federal tax credit ended, leading to concerns that EVs could become a niche market.
Gold Prices Face Further Downside as Momentum Fades, WGC Warns
The World Gold Council warns that gold prices may retreat further as momentum diminishes amid rising bond yields and conflicting signals from the U.S. Treasury and Federal Reserve, impacting traders a...
Nutriband CEO Gareth Sheridan to Attend Inaugural Nasdaq LaB Biotech Summit
Nutriband CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on Sept. 16, 2026, highlighting the company's focus on abuse-deterrent transdermal pharmaceuticals.
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Stability Data for PTSD Treatment
Silo Pharma announces its participation in the IPAC-RS 2026 Nasal Innovation Forum, where it will discuss advancements in its nose-to-brain drug delivery for PTSD, supported by positive stability data...
Quantum BioPharma's Lucid-MS Clears FDA Phase 2 Trial Hurdle, Sparking Analyst Optimism
Quantum BioPharma's Lucid-MS, a potential first-in-class treatment for multiple sclerosis, has received FDA clearance for Phase 2 trials, drawing a new buy rating from Wall Street analysts.
Powermax Minerals Completes 2026 Field Program at Cameron Rare Earth Project, Advances Critical Mineral Supply Amid Global Shortage
Powermax Minerals has finished its 2026 exploration at the Cameron REE project in British Columbia, collecting 250 samples for lab analysis, as the company positions itself to address the growing dema...
Nicola Mining's Treasure Mountain Mine Found in Better-Than-Expected Condition, Paving Way for 2027 Restart
Nicola Mining's independent assessment of its Treasure Mountain Silver Mine reveals the mine is in better condition than anticipated after 13 years of inactivity, potentially expediting the planned 20...
Quantum BioPharma's Lucid-MS Receives FDA Clearance for Phase 2 Trial, Drawing Analyst Buy Rating
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protecting drug candidate for multiple sclerosis, has received FDA clearance to begin a Phase 2 clinical trial, prompting a new buy rating from Wa...
Ladybug Resource Group Launches Strategic M&A Initiative Targeting AI-Driven Software Platforms
Ladybug Resource Group has initiated a strategic acquisition program to identify and evaluate AI-powered software and digital supply chain companies, complementing its manufacturing operations and Min...
Frontieras North America Signs LOI with Cora Terminal for Multi-Phase FASForm Deployment in Illinois
Frontieras North America has signed a Letter of Intent with Cora Terminal, LLC to develop up to two FASForm production facilities in Illinois, marking its third commercial site and potentially process...
Datavault AI Responds to Shareholder Litigation, Reaffirms Operational Priorities
Datavault AI addresses shareholder litigation and reaffirms its commitment to its operational strategy, including technology commercialization and revenue growth.
Rail Vision Renames MainLine and ShuntingYard Systems as TrackScout and YardFlow Flex
Rail Vision Ltd. rebrands its flagship products to better reflect their capabilities, aiming to strengthen market positioning and enhance safety and efficiency in railway operations.
Helus Pharma CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference
Helus Pharma's CEO will discuss the company's clinical programs and progress at a major investment conference, highlighting its novel serotonergic agonists for mental health conditions.
BOXABL Highlights Nationwide Deployments of Factory-Built Housing, From Wildfire Relief to Eco-Luxury Resorts
BOXABL's portfolio of modular housing projects across the U.S. demonstrates its expanding role in addressing housing affordability and disaster relief, with deployments ranging from permanent RV parks...
Moody Capital Solutions to Host 2026 Disruptive Growth & Life Sciences Conference
Moody Capital Solutions will host its 2026 Disruptive Growth & Life Sciences Conference, a two-day event designed to connect investors with emerging and under-covered companies in the disruptive growt...
ROS® and FranMan Release Updated Franchise Recruitment Manual
Recruitment Operating System (ROS®) has released an updated Franchise Recruitment Manual, created with FranMan, to reflect modern recruiting tools and best practices, including analytics and AI.
GeoVax Welcomes Global Mpox Vaccine Stockpile, Highlights GEO-MVA Readiness
GeoVax Labs supports the new Gavi-funded global mpox vaccine stockpile, emphasizing its GEO-MVA candidate's potential to diversify supply and strengthen preparedness.
FUNDbeat Launches Competitive Intelligence Platform for Canadian Fund Companies
FUNDbeat Inc. introduces a new platform that monitors and structures publicly available fund company content, enabling marketing and product teams to compare competitors and identify evolving patterns...
Bain Capital and Omnam Group Sell Lake Como EDITION Hotel to Sansiri Capital
Bain Capital and Omnam Group have sold The Lake Como EDITION to Sansiri Capital, marking the completion of a transformative redevelopment and Sansiri's strategic entry into Europe's luxury hospitality...
ORGANA International Brings Nearly Three Decades of Natural Wellness Experience to ECRM
ORGANA International, a wellness company with nearly 30 years in business, will meet with retail buyers at ECRM to expand its U.S. retail presence and introduce its diverse product line to a broader a...